Search

Chair: Dr David Gurney
COVID-19
9.00 Gene therapy: Curing the incurable! Dr Rashid Kazmi, University Hospital Southampton NHS Foundation Trust
9.30 Anticoagulation in COVID-19: What does not kill
Dr Andrew Godfrey, The Royal Marsden NHS Foundation Trust
Haemostasis
10.30 The rise of misinformation and the role of science education
Rev Dr Gordon Sinclair, London Metropolitan University
11.00 Q&A. What we learnt from COVID-19 Dr Steve Kitchen and Dr Annette Bowyer, The Royal Hallamshire Hospital; and Dr Gary Moore, Technoclone

Chair: Sean Conlan
14.00 Human leucocyte antigen epitopes
Dr Richard Battle, Scottish National Blood Transfusion Service
14.30 Clinical applications of the predicted indirectly recognisable HLA epitopes (PIRCHE) software tool in solid organ and bone marrow transplant Neil Marsden, Leeds Teaching Hospitals NHS Trust
15.00 Cell and Gene therapy: Manufacturing support to the NHS
Dr Katy Latham, NHS Blood & Transplant
16.00 Genomics of inborn errors of
immunity - from rare variants to clinically actionable findings Prof. Sophie Hambleton, Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust

Chair: Dina Patel
9.00 Neuroscience laboratories services Katherine Birch, The Walton Centre NHS Foundation Trust
9.30 Testing for the investigation of myasthenia gravis Dr Ross Sadler, Oxford University Hospitals NHS Foundation Trust
10.30 Myositis antibodies: Are we missing something?
11.00 Autoimmune bullous dermatoses: beyond the green screen
Dr John Mee, Viapath Analytics - An NHS partnership with SYNLAB
11.30 Serological testing for immune- mediated lung disease
Dr Adrian Heaps, North Cumbria Integrated Care NHS Trust

9.00 Decision making in a crisis situation
9.30 Developing confident leadership at all levels
10.30 Positive onboarding – making staff induction an investment for success
Sue Alexander, Royal Marsden NHS Foundation Trust
11.00 Lead, follow or get out of the way Glenn Noel-Storr, Royal Marsden NHS Foundation Trust, Chelsea
11.30 Applying organisation values to your leadership Sue Alexander, Royal Marsden NHS Foundation Trust

Chair: Ian Cocking
9.00 What the future holds in Microbiology - precision AMR project Francis Yongblah, Great Ormand Street Hospital for Children NHS Foundation Trust
9.30 Narrative Authorising -an extend role for biomedical scientists
Dr Michael Simmons, Public Health Wales
10.30 Advanced Clinical Practice in Microbiology Greg Williams, Public Health Wales
11.00 Long term quality improvement in microbiology
Matt O’Dwyer, University Hospital Southampton NHS Foundation Trust
11.30 Methods for the isolation of nontuberculous
mycobacteria (NTM) from respiratory samples and the environment Prof. John Perry, Newcastle upon
Tyne Hospitals NHS Foundation Trust

Chair: Matthew O’Dwyer
9.00 HSST experience in Microbiology
Phillipa Burns, Hull University Teaching Hospitals NHS Trust
9.30 A drive for change: a Queen’s Medical Centre perspective Bhavin Mistry, Nottingham University Hospitals NHS Trust
10.30 From Acrophialophora to Zygosaccharomyces: Expanding the potential of the Bruker Biotyper for fungal identification
Dr Mark Fraser, UK National Mycology Reference Laboratory, UK Health Security Agency
11.00 Rapid identification from blood cultures
Robert Impey, Portsmouth University Hospitals Trust
11.30 The microbiome and mental health
- potential future diagnostics in microbiology Matthew Fairbrother, University Hospitals of
Derby and Burton NHS Foundation Trust

Chair: Jessica Jones
9.00 Managing
O-negative red cells in hospital transfusion laboratories
Jill Caulfield, NHSBT
9.30 Ensuring continuity of the blood supply to English hospitals during the COVID-19 pandemic
Dean Neill, NHSBT
10.30 Managing hospital transfusion during a pandemic Karen Madgwick, North Middlesex University Hospital NHS Trust
11.00 Introduction of a new blood component Michael Wiltshire, NHSBT
11.30 Did convalescent plasma work in COVID patients?
Professor Lise Estcourt, NHSBT

Chair: Mike Palmer
9.00 Major Haemorrhage – a
laboratory perspective Newcastle Hospitals
NHS Foundation Trust
9.20 How electronic requesting systems for blood products like ICE could be utilised to reduce incidences of TACO
Natalie Hennessy, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
09.40 HDFN caused by Anti-K
Gemma Harte, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust
10.30 Blood group – Kidd
Martin Maley, University of Sunderland
11.00 Blood Group – MNSs
Dr Tom Bullock, Red Cell
Immunohaematology - NHSBT
11.30 International Blood Group Reference Laboratory (IBGRL)
– finding new blood group antigens Shane Grimsley, International Blood Group Reference Laboratory - NHSBT
12.45 Antibody workshop
Jill Caulfield, NHSBT and Martin Maley, University of Sunderland

09.00 Pathology GIRFT: Next steps and implementing the recommendations
Dr Martin Myers, Dr Marion Wood and Tom Lewis, NHS England & Improvement
09.30 Pathology Quality Assurance Dashboard: The early years Jane Mills and Bruce Daniel, NHS England & Improvement
10.30 UKAS Update: The current challenges and opportunities
Lorraine Turner, UKAS
11.00 Accreditation to support the pandemic response- Private providers of covid 19 sampling and testing
Alyson Bryant, UKAS
11.30 Optimising UKAS Assessments
John Ringrow, UKAS

Chair: Dr Alistair Gammie 9.00 New Strategies or new diseases – capacity building Laura Ryall, UK Health Security Agency
9.30 New strategies for new diseases – crowdsourcing to resolve problems Prof. Jo Martin, NHS England and NHS Improvement
10.30 Pandemic response – from zero to 1 million tests
a day. Innovation, lessons learned and legacy
Melanie Smith, National Infection Service, UK Health Security Agency
11.00 Pandemic response – impact on vaccination programme and virus resurgence
Dr Kevin Brown, UK Health Security Agency
11.30 Pandemic response and impact
– economic impact on research and scientific development
Dr Bethan Hussey, Wellcome Sanger Institute